Medvi Achieves Milestone Sales Amid Rapid Growth
Medvi, a telehealth provider specializing in GLP-1 drugs, is on track to reach $1.8 billion in sales in 2026, following a remarkable growth trajectory.
Medvi, a telehealth provider specializing in GLP-1 drugs, is on track to reach $1.8 billion in sales in 2026, following a remarkable growth trajectory.